Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PONROY VITARMONYL BENELUX from Tournai, company number BE0867773381, closed financial year 2025 with a result of € -2.7 million after tax. For that financial year PONROY VITARMONYL BENELUX recorded revenue of € 895,202 and equity of € -13.3 million. Compared with financial year 2024, the result moved from € -4.2 million to € -2.7 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ -13.3 million
▼ € 2.7 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.7 million
▲ 35 % less loss than in 2024
Profit after tax over the fiscal year.
€ 29,647
▼ 36% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -13.3 million.
People and assets in 2025
4
▼ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 205,460
▼ 25% vs 2024
€ 51,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.5 million
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 475 days on average.
€ 41,022
▲ 14% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,812,641 | € 1,551,037 | € 959,451 | € 895,202 | ▼ 7% |
| Profit after taxes | € -2,259,707 | € -2,556,327 | € -4,169,529 | € -2,700,917 | ▲ € 1.5 million |
| Equity | € -3,866,725 | € -6,423,052 | € -10,592,581 | € -13,293,498 | ▼ € 2.7 million |
| Total debts | € 46,217,653 | € 48,748,296 | € 52,154,047 | € 54,523,068 | ▲ 5% |
| Cash | € 63,230 | € 48,969 | € 46,176 | € 29,647 | ▼ 36% |
| Retained profit | € -3,885,325 | € -6,441,652 | € -10,611,181 | € -13,312,098 | ▼ € 2.7 million |
| Balance sheet total | € 42,350,928 | € 42,325,244 | € 41,561,466 | € 41,229,570 | ▼ 1% |
| Employees (FTE) | 5.7 | 4.8 | 5.1 | 4 | ▼ 1.1 |
Key figures of PONROY VITARMONYL BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PONROY VITARMONYL BENELUX?
What happened at PONROY VITARMONYL BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 2.7 million. filed late Source: NBB ↗
- New establishment in Antwerpen. KBO
- Bon Topco became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Antwerpen. KBO
In short
From € 2.3 million loss in 2022 to € 2.7 million loss in 2025.
Paid € 100,229 in corporate taxes since 2022.
A new publication or filing at PONROY VITARMONYL BENELUX? We notify you, reason included.
Follow PONROY VITARMONYL BENELUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PONROY VITARMONYL BENELUX is Bon Topco. It owns 100% of ixX Pharma itself.
Directors
According to the 2025 annual accounts
Director · represented by Nicolas Brodetsky
Also active at: Laboratoire Densmore Belgium, BIOCYTE BENELUX
since 2023
Establishments
Establishment units
Physical locations of this company
Chaussée de Lille(TOU) 327/1.4
7500 Tournai
Borsbeeksebrug 34
2600 Antwerpen
Active since 11 October 2004
Borsbeeksebrug 34 box 401
2600 Antwerpen
Active since 1 July 2025
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.773.381
- VAT number
- BE 0867.773.381
- Registered office
- Chaussée de Lille(TOU) 327/1.4, 7500 Tournai
- Names & denominations
- PONROY VITARMONYL BENELUX · P.V.B.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 October 2004
- Peppol
- Active · Active since 30 Jul 2025
- Activities · NACE
Groothandel in andere voedingsmiddelen, neg
Overige gespecialiseerde groothandel in voedingswaren
Groothandel in parfumerieën en cosmetica
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten